Aging is not a single event—it is a set of interconnected biological processes that unfold at the cellular level over time. The VSELs Anti-Aging Protocol at The Longevity Center FL is an emerging regenerative approach that utilizes Very Small Embryonic-Like Stem Cells (VSELs)—cells derived from your own blood—within the context of a physician-guided longevity strategy. Supervised by Dr. Benjamin Kosubevsky, with advanced training in Osteopathic, Regenerative, and Integrative Medicine, this protocol is available to patients in West Palm Beach and across South Florida who are interested in exploring cellular-level approaches to supporting healthspan and wellness as they age.
This page describes the longevity-specific application of VSEL therapy. For information about VSELs in the context of musculoskeletal and regenerative medicine, please visit our general VSELs page.
Important Regulatory Notice
VSEL therapy has NOT been approved by the U.S. Food and Drug Administration (FDA) for any indication, including anti-aging, longevity, or cellular rejuvenation. VSELs are an autologous blood-derived cell population; the therapy involves isolation, activation, and reintroduction of these cells under physician supervision. Clinical research on VSELs in humans is in early stages, and the evidence base for longevity-specific applications is limited. The term “anti-aging” as used on this page refers to wellness strategies aimed at supporting cellular health and function, not to the treatment, cure, or prevention of any disease or the reversal of biological aging. Individual results vary, and no specific health outcomes are promised or guaranteed. This service is not a substitute for evaluation by your primary care physician.
In 2023, an updated framework published in Cell identified twelve hallmarks of aging—interconnected biological processes that contribute to age-related functional decline. These include genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, cellular senescence, mitochondrial dysfunction, and stem cell exhaustion, among others (López-Otín et al., Cell, 2023).
Among these hallmarks, stem cell exhaustion—the gradual decline in the number and regenerative capacity of adult stem cells—is recognized as a central driver of tissue deterioration with age. Peer-reviewed research has described how aging stem cells lose their ability to maintain and repair tissues, contributing to the functional decline observed across organ systems (Oh et al., Nature Medicine, 2014; Goodell & Rando, Science, 2015).
Very Small Embryonic-Like Stem Cells (VSELs) are a population of small, pluripotent cells first identified in adult bone marrow by Kucia, Ratajczak, and colleagues in research published in Leukemia (2006). Unlike other adult stem cells, VSELs are characterized by their extremely small size, expression of embryonic markers, and potential for multi-lineage differentiation. These cells are present in the body in a quiescent (dormant) state and are hypothesized to serve as a reserve regenerative population.
It is important to note that VSEL biology is an active area of scientific investigation. While the original characterization has been published in peer-reviewed journals, the full scope of VSELs’ regenerative capacity in humans—and particularly in the context of aging—is still being studied. Not all findings have been uniformly replicated across research groups, and the field continues to evolve.
At The Longevity Center FL, the VSELs Anti-Aging Protocol follows a structured, physician-supervised process:
A small blood sample is drawn from the patient in a minimally invasive procedure, similar to a standard blood draw.
Using specialized laboratory techniques, VSELs are isolated from the blood sample and separated from other cell populations.
The isolated VSELs undergo an activation process designed to stimulate their regenerative potential. This may involve proprietary activation techniques, including laser-based cellular stimulation.
The activated VSELs are reintroduced into the patient’s body via intravenous infusion, where they enter systemic circulation. The hypothesis underlying this approach is that activated VSELs may migrate to areas of cellular stress, inflammation, or tissue need.
Following the procedure, Dr. Kosubevsky monitors your response and integrates the VSEL protocol within your broader Longevity Roadmap. The anti-aging protocol may be repeated at intervals determined by your clinical response and wellness goals.
The VSELs Anti-Aging Protocol is positioned within a broader understanding of cellular aging. Cellular senescence—the process by which cells lose their ability to divide and function properly—has been described as a key contributor to age-related tissue decline and chronic inflammation (Campisi, Annual Review of Physiology, 2013). The scientific rationale for stem cell-based longevity approaches is rooted in the idea that supporting or replenishing the body’s regenerative cell populations may help maintain tissue function as we age.
This rationale is still being validated through ongoing research. At this time, the VSELs Anti-Aging Protocol is offered as an emerging wellness modality—not as a proven anti-aging treatment—under physician supervision with transparent communication about what the evidence does and does not yet support.
For patients who are actively investing in their long-term wellness and want to explore emerging cellular-level approaches as part of a comprehensive longevity strategy.
For those who are already working with Dr. Kosubevsky on hormone optimization, peptide therapy, IV nutrient support, or other longevity-focused services and want to add a stem cell-based component to their plan.
For patients who prefer treatments derived from their own body rather than external sources, and who are comfortable with the emerging nature of this field.
The VSELs Anti-Aging Protocol is most meaningful when informed by comprehensive baseline data. Patients who have completed the Longevity & Wellness Assessment have the clinical context needed to make this protocol part of a data-informed plan.
Dr. Benjamin Kosubevsky combines conventional medical training with advanced experience in integrative, regenerative, and osteopathic medicine. For patients interested in the VSELs Anti-Aging Protocol, Dr. Kosubevsky provides:
The VSELs Anti-Aging Protocol at The Longevity Center FL represents one of the newest frontiers in regenerative wellness. It is offered with transparency about its emerging status and within the framework of a physician-guided longevity strategy. If you are interested in exploring cellular-level approaches to supporting how you age, we welcome the opportunity to discuss whether this protocol may be appropriate for you.
Schedule a consultation to discuss whether the VSELs Anti-Aging Protocol is appropriate for your longevity goals.
Medical & Regulatory Disclaimer
The information on this page is provided for educational purposes only and does not constitute medical advice, diagnosis, or treatment. VSEL therapy has NOT been approved by the U.S. Food and Drug Administration for any indication, including anti-aging, longevity, tissue rejuvenation, or any specific disease or condition. VSELs are an autologous blood-derived cell population; research on their therapeutic applications in humans is in early stages and the evidence base is still developing. The term “anti-aging” as used on this page refers to wellness strategies aimed at supporting cellular health and function; it does not imply the reversal, cure, or prevention of biological aging or any disease process. Not all published findings on VSELs have been uniformly replicated across research groups. Individual results vary significantly, and no specific outcomes are promised or guaranteed. This service is not a substitute for evaluation and care by your primary care physician. Always consult a qualified healthcare professional regarding any medical condition, symptom, or treatment decision. Peer-reviewed research cited on this page reflects laboratory, preclinical, or review-level findings and does not predict individual clinical outcomes.
1. Kucia M, Reca R, Campbell FR, et al. A population of very small embryonic-like (VSEL) CXCR4(+)SSEA-1(+)Oct-4+ stem cells identified in adult bone marrow. Leukemia. 2006;20(5):857-869.
2. López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: An expanding universe. Cell. 2023;186(2):243-278.
3. Campisi J. Aging, Cellular Senescence, and Cancer. Annual Review of Physiology. 2013;75:685-705.
4. Goodell MA, Rando TA. Stem cells and healthy aging. Science. 2015;350(6265):1199-1204.
5. Oh J, Lee YD, Wagers AJ. Stem cell aging: mechanisms, regulators and therapeutic opportunities. Nature Medicine. 2014;20(8):870-880.
Schedule your appointment today and take the first step toward a healthier, more balanced life.
Schedule an Appointment